Savara announces proposed public offering of common stock

Austin, texas--(business wire)--savara inc. (nasdaq: svra), an orphan lung disease company, today announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. in addition, savara is offering to certain investors the right to purchase pre-funded warrants in lieu of common stock. the offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or a
SVRA Ratings Summary
SVRA Quant Ranking